Piramal Imaging to release florbetaben findings

10/17/2013 | PRNewswire

Piramal Imaging will release data from studies of the company's PET imaging agent F-18 florbetaben at the 2013 Annual Congress of the European Association of Nuclear Medicine in France. Florbetaben is being evaluated by the FDA and the European Medicines Agency for the detection of beta-amyloid plaques in patients with Alzheimer's disease and other neurodegenerative conditions.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Fort Worth, TX
Director, Senior Legal Counsel
Fort Worth, TX
Corporate Counsel - Healthcare Law Group
South San Francisco, CA
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC